The efficacy of ICBs is closely related to immune cell infiltration, especially CD8+ CTL infiltration.3 Several studies have shown that RT can remodel the tumor immune microenvironment and promote the infiltration and activation of CD8+ T cells.11 31 Therefore, the combination of RT and immunotherapy exhibits synergistic effects in many kinds of tumors. This evidence concerns the gene CD8A and neoplasm.